Cargando…
A case series of blastic plasmacytoid dendritic cell neoplasia
Blastic plasmacytoid dendritic cell neoplasm (BPDCN), an extremely rare and aggressive tumor, derives from plasmacytoid dendritic cell precursors and is characterized by CD4 and CD56 positivity accompanied by the expression of isolated myeloid, B- or T-cell lineage markers. Despite the recent introd...
Autores principales: | Serio, B, Giudice, V, D’Addona, M, Guariglia, R, Gorrese, M, Bertolini, A, D’Alto, F, Cuffa, B, Pellegrino, D, Langella, M, Selleri, C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Università di Salerno
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8370518/ https://www.ncbi.nlm.nih.gov/pubmed/33457326 http://dx.doi.org/10.37825/2239-9747.1012 |
Ejemplares similares
-
Post-therapy B Regulatory Cells Might early Predict Relapse in Hodgkin Lymphoma
por: Giudice, Valentina, et al.
Publicado: (2022) -
Implementation of International Prognostic Index with flow cytometry immunophenotyping for better risk stratification of chronic lymphocytic leukemia
por: Giudice, Valentina, et al.
Publicado: (2022) -
Blastic Plasmacytoid Dendritic Cell Neoplasia: A Single Center Experience
por: Demiröz, Ahu Senem, et al.
Publicado: (2020) -
Blastic plasmacytoid dendritic-cell neoplasia: a challenging case report
por: Koerber, Ruth-Miriam, et al.
Publicado: (2021) -
WT1 Expression Levels Combined with Flow Cytometry Blast Counts for Risk Stratification of Acute Myeloid Leukemia and Myelodysplastic Syndromes
por: Giudice, Valentina, et al.
Publicado: (2021)